Major Investor Quietly Boosts Stake in Emerging Biotech PlayerTip Ranks·2 days ago, 09:01 PMBOLD+0.79%
Boundless Bio 10% owner Kevin Tang acquires $11,876 in common sharesPUBT·2 days ago, 06:39 PMBOLD+0.79%
Tang Capital’s Kevin Tang reports $154,586 Boundless Bio common share purchasePUBT·Jul 16 at 07:11 PMBOLD+0.79%
Tang Capital’s Kevin Tang reports $238,263 purchase of Boundless Bio common sharesPUBT·Jul 13 at 06:06 PMBOLD+0.79%
Kevin Tang reports $141,464 purchase of 57,210 Boundless Bio common sharesPUBT·Jul 8 at 07:06 PMBOLD+0.79%
ARCH Venture Fund IX disposes of 16,000 Boundless Bio common shares worth $39,840PUBT·Jul 6 at 04:44 PMBOLD+0.79%
Boundless Bio 10% owner Kevin Tang reports $272,474 common share purchasePUBT·Jul 2 at 06:46 PMBOLD+0.79%
13:42 ETSHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ACA, APGE, BOLD, and GBCSprnewswire·Jul 2 at 12:42 PMBOLD+0.79%ACA-0.11%
Boundless Bio files initial beneficial ownership statement by Kevin TangPUBT·Jun 29 at 06:53 PMBOLD+0.79%
Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders?PR Newswire·Jun 25 at 12:53 PMREFI+1.39%BOLD+0.79%
Sangamo holds a bankruptcy sale; VCs back a China-linked Beam competitorbiopharmadive·Jun 24 at 09:32 AMMKKGY+0.50%SNY+0.12%
Top Biotech Gainers: BOLD Begins Anew, MNPR NDA Filing On Track, GALT Soars On FDA Alignmentrttnews·Jun 23 at 10:15 PMGALT-0.58%EDSA-4.59%
